日本一高清二区视频久而久二,午夜自产精品一区二区三区,成人三级视频在线观看一区二区,77色77国产欧美在线精品

    <dfn id="n52vb"></dfn>

    <legend id="n52vb"><u id="n52vb"><blockquote id="n52vb"></blockquote></u></legend>

    1. <listing id="n52vb"></listing>
      1. R&D Capability
        Home Innovation

        R&D Capability

        R&D Capability

        Remarkable R&D capabilities with over 20 years of R&D experience, Jiangsu Hansoh Pharma has several national-level R&D destinations, including the National Enterprise Technology Centers, Post-doctoral Research Station, and Key National Laboratory. The Company is highly efficient to discover innovative drugs, with R&D structure that covers areas such as peptides, biologics, small molecules, ADC drugs, and siRNAs.

        • 7
          launched innovative drugs
        • 40
          innovative drug candidates
        • 60 +
          clinical trials of innovative drug candidates being investigated
        • 60 +
          national scientific research projects such as 863 Program, Major Science and Technology Program for Innovation and Development of Significant New Drugs, and Torch Program
        • 2
          second prizes of National Science and Technology Progress Award
        • 2
          China Patent Gold Award
        • 600 +
          authorized invention patents at home and abroad
        • 200 +
          contributions to national standards
        R&D Team
        • 3
          State Council Special Allowance Experts
        • 16
          Jiangsu "innovative and entrepreneurial talent"
        • 9
          Jiangsu "333 talent project"
        • 1800 +
          R&D fellows in China and abroad